Transverse B-Lynch in Management of Placenta Accreta

Decrease Maternal Morbidity Clinical Trial

Official title:

Evaluation of the Efficacy of Transverse B-Lynch in Management of Placenta Accreta

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02943421
• Other study ID #: MAP
• Status: Completed
• Start date: December 1, 2016
• Est. completion date: May 5, 2018

Study information

• Verified date: June 2018
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Placenta accreta is considered a severe pregnancy complication that may be associated with massive and potentially life-threatening intrapartum and postpartum hemorrhage. Life-threatening bleeding is the most common complication to be associated with this condition; the average blood loss at time of delivery is reported to be 3000-5500 mL, which leads to significant postoperative morbidity and death.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: May 5, 2018
• Est. primary completion date: February 3, 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

1. All pregnant women with placenta previa as diagnosed by ultrasound with suspicion of abnormal placentation by Doppler us, confirmed intraoperatively undergoing either emergent or elective cesarean

Exclusion Criteria:

1. Patients who will be managed by hysterectomy

2. Patients who will be managed by conservative leaving the placenta in-situ

Related Conditions & MeSH terms

• Decrease Maternal Morbidity
• Placenta Accreta

Intervention

Procedure:
• Transverse B-Lynch suture

Locations

Country	Name	City	State
Egypt	Ahmed Abbas	Assiut	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Estimated intraoperative blood loss		30 min